CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CYMABAY THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,906,455
+310.7%
798,555
+201.6%
0.00%
+200.0%
Q2 2023$2,898,837
+763.9%
264,734
+588.0%
0.00%
Q1 2023$335,546
+54.8%
38,480
+11.3%
0.00%
Q4 2022$216,729
+79.1%
34,5660.0%0.00%
Q3 2022$121,000
-16.0%
34,566
-28.9%
0.00%
Q2 2022$144,000
-80.6%
48,612
-79.7%
0.00%
Q1 2022$744,000
+22.2%
239,215
+32.9%
0.00%
Q4 2021$609,000
-4.1%
179,959
+3.4%
0.00%
Q3 2021$635,000
-72.6%
173,959
-67.3%
0.00%
-100.0%
Q2 2021$2,317,000
-5.4%
531,334
-1.4%
0.00%0.0%
Q1 2021$2,448,000
-18.0%
539,114
+3.7%
0.00%0.0%
Q4 2020$2,984,000
-20.8%
519,693
-0.1%
0.00%
-50.0%
Q3 2020$3,768,000
+147.6%
520,418
+19.4%
0.00%
+100.0%
Q2 2020$1,522,000
+173.7%
435,930
+16.2%
0.00%
Q1 2020$556,000
-23.3%
375,265
+1.5%
0.00%
Q4 2019$725,000
-63.8%
369,704
-5.5%
0.00%
-100.0%
Q3 2019$2,003,000
-28.8%
391,098
-0.5%
0.00%
-50.0%
Q2 2019$2,815,000
-41.9%
393,123
+7.7%
0.00%
-33.3%
Q1 2019$4,847,000
+90.3%
364,918
+12.8%
0.00%
+50.0%
Q4 2018$2,547,000
-29.4%
323,599
-0.6%
0.00%0.0%
Q3 2018$3,609,000
+106.6%
325,651
+150.2%
0.00%
+100.0%
Q2 2018$1,747,000
+559.2%
130,165
+539.2%
0.00%
Q1 2018$265,000
+130.4%
20,365
+63.4%
0.00%
Q4 2017$115,00012,4650.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,254,502$20,741,00014.54%
Versant Venture Management, LLC 1,048,601$9,647,127,00010.15%
Abingworth LLP 1,147,077$10,553,0007.65%
Omega Fund Management, LLC 551,477$5,074,0003.67%
Opaleye Management Inc. 665,000$6,118,0001.96%
DAFNA Capital Management LLC 361,164$3,323,0001.79%
Boxer Capital, LLC 1,012,986$9,319,0001.70%
Foresite Capital Management III, LLC 600,000$5,520,0001.55%
NEXTHERA CAPITAL LP 536,568$4,936,0000.91%
Perceptive Advisors 2,685,882$24,710,0000.82%
View complete list of CYMABAY THERAPEUTICS INC shareholders